2 Clinical-Stage Biopharma Stocks With Triple-Digit Upside Potential
Analysts at Wells Fargo – and the broader analyst community – see triple-digit upside potential in these two stocks, both clinical-stage biopharmaceutical companies. CLICK HERE.
Ashley Hayes
6 Stocks Offering Both Value And Generous Payouts
These six stocks not only offer value in an overvalued market, they also have relatively high dividend yields. As such, they may be the ideal… Read More »6 Stocks Offering Both Value And Generous Payouts
4 Low-Uncertainty – And Undervalued – Stocks For The Uncertain Weeks Ahead
Pandemic, politics, and economic performance: the coming weeks are likely to bring even greater uncertainty to the market. Given this, it may be worth considering… Read More »4 Low-Uncertainty – And Undervalued – Stocks For The Uncertain Weeks Ahead
Alternative Routes To Electric-Vehicle Profits
If you missed out on Tesla’s massive run-up, fear not: there are still plenty of alternatives to play the electric-vehicle revolution (and which don’t require… Read More »Alternative Routes To Electric-Vehicle Profits
Get Plump Payouts — And Pullback Protection — From Tech Stocks With This Fund
How can you get big dividends (6%+ payouts) from some of the biggest tech stocks? One way is with this high-yield closed-end fund that offers… Read More »Get Plump Payouts — And Pullback Protection — From Tech Stocks With This Fund
Holdings, Purchases And Sales Of The “Ultimate Stock-Pickers”
What stocks have top stock pickers been holding, buying and selling with conviction in recent months? Here are the top 10 stock holdings, purchases and… Read More »Holdings, Purchases And Sales Of The “Ultimate Stock-Pickers”
Crash Course
From Tesla and Apple’s high-flying valuations to retail investors going wild on trading apps like Robinhood to the market’s volatility/fear index creeping higher, there are… Read More »Crash Course
The Dividend Aristocrats & The COVID Cutters
While dozens of S&P 500 companies have suspended or lowered their dividend payments during the pandemic, the S&P 500 Dividend Aristocrats have (thus far) been… Read More »The Dividend Aristocrats & The COVID Cutters
Capitalize On Healthcare Innovation With This Targeted ETF
Healthcare innovation is poised to be a lucrative thematic investment opportunity going forward – and with small-to-mid sized companies increasingly being the source of such… Read More »Capitalize On Healthcare Innovation With This Targeted ETF
The Big Names, Smaller Newcomers, And Emerging Market Players In The Race For A COVID Cure
From prominent names such as Moderna to smaller newcomers such as Tyme Technologies to emerging market players such as Indian biotech Cipla, here are some… Read More »The Big Names, Smaller Newcomers, And Emerging Market Players In The Race For A COVID Cure